• about axogen
    • management team
    • board of directors
    • careers
    • partners
    • esg report
    • code of ethics and conduct
    • patents
  • investors
  • news
  • contact
    • find a rep
    • international distributors
    • find referring surgeon
  • healthcare professionals
  • patients
COVID-19 Statement A letter from our CEO
Investors
  • Overview
  • News / Events
    • Overview
    • Press Releases
    • Axogen In the News
    • IR Calendar
    • ESG Report
    • Clinical Conferences
    • Presentations
    • Email Alerts
  • Financial Info
    • Overview
    • Balance Sheet
    • Income Statement
    • Cash Flow
    • Financial Results
  • Stock Data
    • Current Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Contact the Board
  • Additional Info
    • Contacts
    • FAQ
  • Investor Tools
    • Email Alerts
    • Tear Sheet
    • Contacts
    • RSS News Feed

Press Releases

Axogen, Inc. to Present at the JMP Securities MedTech Bio Summit

Sep 25, 2020

Axogen to Participate in the 75th Annual American Society for Surgery of the Hand Meeting

Sep 24, 2020

Axogen, Inc. Reports Second Quarter 2020 Financial Results

Aug 5, 2020

Axogen, Inc. to Present at the Canaccord Genuity 40th Annual Growth Conference

Jul 29, 2020

Axogen RECON Clinical Study Completes Target Enrollment of 220 Subjects

Jul 22, 2020

Axogen, Inc. to Report Second Quarter 2020 Financial Results and Host Conference Call on August 5, 2020

Jul 15, 2020

Axogen Announces New Seven-Year Financing Agreement with Oberland Capital and Provides Preliminary Second Quarter Revenue Estimate

Jul 1, 2020

Axogen, Inc. Announces Planned Retirement of Greg Freitag and Appoints Brad Ottinger as General Counsel and Chief Compliance Officer

Jun 1, 2020

Axogen, Inc. to Present at the Jefferies Virtual Healthcare Conference

May 20, 2020

Axogen, Inc. Reports First Quarter 2020 Financial Results

May 6, 2020
RSS
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • ...29
    Next

    13631 Progress Blvd, Suite 400
    Alachua, FL 32615

    • contact
    • careers
    • Privacy Policy
    • Terms of Use
    • Legal Notices
    • Instagram Logo
    • Twitter Logo
    • Linkedin Logo
    • Facebook Logo

    © 2023 Axogen Corporation. The stylized "a" logo, Revolutionizing the Science of Nerve Repair and Avance Nerve Graft are trademarks of Axogen Corporation.

    Top

    You are now leaving axogeninc.com

    Axogen is not responsible for content or policies on linked sites.